RFI-663-22-000005-IQH: Improving Quality of Healthcare (IQH)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Ethiopia USAID-Addis Ababa notices from 2022.
Ethiopia USAID-Addis Ababa offered grants of up to $32.0 million (at least $32.0 million) to any type of organization. It expected to make one award. Applications closed on February 25, 2022.
From the official notice on Grants.gov, last changed January 28, 2022. Checked November 7, 2026.
- Award ceiling$32.0 million
- Award floor$32.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeOther
Key dates
| Posted | January 28, 2022 |
|---|---|
| Deadline | February 25, 2022 |
| Archived by Grants.gov | February 26, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $32.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
Activity Title: Improving Quality of Healthcare (IQH) Reference Number: RFI-663-22-000005-IQH Release Date: January 27, 2022 Response by: February 25, 2022 I. INTRODUCTION This is a Request for Information (RFI) issued solely for information and planning purposes. This is not a Request for Proposals (RFP) or a Request for Applications (RFA) and is not to be construed as a commitment by the U.S. Government to issue any solicitation or Notice of Funding Opportunity, or ultimately award a contract or assistance agreement on the basis of this RFI, or to pay for any information voluntarily submitted as a result of this request. Responses to this RFI shall not be portrayed as proposals and will not be accepted by the U.S. Government (USG) to form a binding agreement. Responders are solely responsible for all expenses associated with responding to this RFI. It should be noted that responding to or providing comment on this RFI will not give any advantage to any organization in any subsequent procurement. USAID/Ethiopia will not provide answers to any question submitted in response to this request. USAID posts its competitive business opportunities on www.fbo.gov or www.grants.gov. It is the potential offeror’s/applicant’s responsibility to monitor these sites for announcements of new opportunities. Responses may be used by USAID without restriction or limitation. II. PURPOSE This RFI on Improving Quality of Health Care Activity solely seeks additional information and inputs from experts, organizations, and/or consortia in the field of quality of health care in general, and in Reproductive, Maternal, Newborn, Child and Adolescent Health (RMNCAH) services in particular. The information received will not be publicly released and will only be used to inform planning decisions. Furthermore, USAID/Ethiopia is not at this time seeking applications or proposals and will not accept unsolicited proposals. USAID/Ethiopia strongly encourages organizations to respond to the questions below after reviewing the draft concept note. Your responses will help USAID to gain a deeper understanding of the quality of care context, current interventions, and approaches for a comprehensive quality improvement program design. Interested parties should provide a short submission, not to exceed 15 pages, addressing the questions below in addition to any comments related to Attachment A. III.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFI-663-22-000005-IQH still open?
No. It closed on February 25, 2022.
Who can apply for Improving Quality of Healthcare (IQH)?
Ethiopia USAID-Addis Ababa accepted applications from any type of organization.
What is the deadline for Improving Quality of Healthcare (IQH)?
Closed February 25, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $32.0 million each.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)